February 23–26 | Marco Island, FL

Late breaking Abstracts due December 10th

Advances in Genome Biology and Technology (AGBT) 

The General Meeting is our flagship event

This year, Advances in Genome Biology and Technology (AGBT) will celebrate 20 years as the preeminent genome science and technology conference where top global researchers, leaders and innovators meet to announce new discoveries, cutting edge breakthroughs and to collaborate. As a recognized cornerstone for the genomics research community, AGBT provides an outstanding forum for exchanging information about the latest advances in DNA sequencing technologies, experimental and analytical approaches for genomic studies, and their myriad applications.

See the
See The
APPLICATIONS

The application process is now closed.

For registration questions, contact the Registrar directly:

1.800.266.0866 or registrar@nixassoc.com
Abstracts

Late breaking Abstracts are due December 10th

Submit your late breaking abstract

Location

Marco Island, Florida

2019 Demographics

Attendees

Universities And Nonprofits

Companies

CEOS, CMOS, and CSOS

  • North America
  • Europe
  • Asia
  • Australia
  • Africa

2019 COUNTRIES IN ATTENDANCE

Australia | Austria | Belgium | Canada | Chile | China | Denmark | Finland | France | Germany | Israel | Japan | Kenya | Mexico | Netherlands 
Qatar | Singapore South | Africa | 
Spain | Sweden | Switzerland | Taiwan Thailand | United Arab Emirates | United Kingdom | United States

2019 United States Attendees

Attendance 2012–2019

Institutions 2012–2019

For more Information

 

AGBT 2018 General Meeting

Orlando, Florida
The cutting edge science, new applications, and access to true leaders always makes AGBT stand out.
— 2018 General Meeting Attendee

AGBT is a cornerstone in genomics and the most important meeting I attend all year.
— 2018 General Meeting Attendee

High level networking and discussion of hard core science and technology is why AGBT is exceptional.
— 2018 General Meeting Attendee

The Scientific
Organizing Committee

Penelope Bonnen, Baylor College of Medicine
Federica Di-Palma, Earlham Institute, University of East Anglia
Kim Doheny, Johns Hopkins Institute of Genetic Medicine
Eric Green, National Human Genome Research Institute /National Institute of Health
Martin Hirst, University of British Columbia
Stephen Montgomery, Stanford University School of Medicine
Christopher Mason, Weill Cornell Medicine
John McPherson, University of California Davis
Len Pennacchio, Lawrence Berkeley National Laboratory
Beth Shapiro, University of California Santa Cruz
Michael Zody, New York Genome Center